Evidence against a synergistic effect of desmopressin with conditioning in the treatment of nocturnal enuresis

Journal of Pediatrics

Volumn 144, Issue 3, 2004, Pages 351-357

  Gibb, Susie ^b   Nolan, Terry ^a   South, Mike ^b   Noad, Lea ^b   Bates, Giles ^b   Vidmar, Suzanna ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN;

ADOLESCENT; AEROSOL; ARTICLE; CHILD; CLINICAL TRIAL; CONDITIONING; CONTINENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG POTENTIATION; FEMALE; FLIGHT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NOCTURNAL ENURESIS; OUTCOMES RESEARCH; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 1542721072     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2003.12.019     Document Type: Article

References (24)

1. Bower WF, Moore KH, Shepherd RB, Adams RD. The epidemiology of childhood enuresis in Australia. Br J Urol 1996;78:602-6.
2. Watanabe H. Sleep patterns in children with nocturnal enuresis. Scand J Urol Nephrol 1995;173(suppl):37-42.
3. Wolfish NM, Pivik RT, Busby KA. Elevated sleep arousal thresholds in enuretic boys: clinical implications. Acta Paediatr 1997;86:381-4.
4. Schaumburg HL, Rittig S, Djurhuus JC. No relationship between family history of enuresis and response to desmopressin. J Urol 2001;166:2435-7.
5. Hagglof B, Andren O, Bergstrom E, Marklund L, Wendelius M. Self esteem before and after treatment in children with nocturnal enuresis and urinary incontinence. Scan J Urol Nephrol 1996;183(suppl):79-82.
6. Forsyth WI, Butler RJ. Fifty years of enuresis alarms. Arch Dis Child 1989;64:879-88.
7. Kristenson G, Jensen IN. Meta-analyses of results of alarm treatment for nocturnal enuresis reporting practice, criteria and frequency of bed wetting. Scand J Urol Nephrol 2003;37:232-8.
8. Riccabona M, Oswald J, Galuninger P. Long term use and tapered dose reduction of intranasal desmopressin in the treatment of 155 enuretic children. Br J Urol 1998;81(suppl):26-8.
9. Tullus K, Bergstrom R, Fosdal I, Winnergard I, Hjalmas K. Efficacy and safety during long-term treatment of primary monosymptomatic nocturnal enuresis with desmopressin. Acta Paediatr 1999;88:1274-8.
10. Bradbury MG, Meadow SR. Combined treatment with enuresis alarm and desmopressin for nocturnal enuresis. Acta Paediatr 1995;84:1014-8.
11. Leebeek-Groenwegen A, Blom J, Sukhai R, Van der Heijden B. Efficacy of desmopressin combined with alarm therapy for monosymptomatic nocturnal enuresis. J Urol 2001;166:2456-8.
12. Butler RJ, Holland P. The three systems: a conceptual way of understanding nocturnal enuresis. Scand J Urol Nephrol 2000;34:270-7.
13. Neveus T, Lackgren G, Tuvemo T, Hetta J, Hjalmas K, Stenberg A. Enuresis: background and treatment. Scand J Urol Nephrol 2000; 206(suppl):1-44.
14. Yeung CK, Chiu HN, Sit FK. Bladder dysfunction in children with refractory monsymptomatic primary nocturnal enuresis. J Urol 1999;162:1049-1055.
15. Hamano S, Yamanishi T, Igarashi T, Ito H, Murakami S. Functional bladder capacity as a predictor of response to desmopressin and retention control training in monosymptomatic nocturnal enuresis. Eur J Urol 2000;37:718-22.
16. Neveus T, Tuvemo T, Lackgren G, Stenberg A. Bladder capacity and renal concentrating ability in enuresis: pathogenic implications. J Urol 2001;165:2022-5.
17. Watanabe H, Azuma Y. A proposal for a classification system of nocturnal enuresis based on overnight simultaneous monitoring of electroencephalography and cystometry. Sleep 1989;12:257-64.
18. Devitt H, Holland P, Butler RJ, Redfern E, Hiley E, Roberts G. Plasma vasopressin and response to treatment in primary nocturnal enuresis. Arch Dis Child 1999;80:448-51.
19. Saito M, Tahara A, Sugimoto T. 1-Desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1-b vasopressin receptor. Biochem Pharmacol 1997;53:1711-7.
20. Muller D, Florkowski H, Chavez-Kattau K, Carlsson G, Eggert P. The effect of desmopressin on short-term memory in children with primary nocturnal enuresis. J Urol 2001;166:2432-4.
21. Beckwith BE, Petros T, Bergloff PJ, Staebler RJ. Vasopressin analog (DDAVP) facilitates recall of narrative prose. Behav Neurosci 1987;101:429-32.
22. Jonat S, Santer R, Schneppenheim R, Obser T, Eggert P. Effect of DDAVP on nocturnal enuresis in a patient with nephrogenic diabetes insipidus. Arch Dis Child 1999;81:57-9.
23. Lackgren G, Lilja B, Neveus T, Stenberg A. Desmopressin in the treatment of severe nocturnal enuresis: a 7-year follow-up study. Br J Urol 1998;81:17-23.
24. Soelberg SP, Vilhardt H, Gjerris F, Warberg J. Impermeability of the blood-cerebrospinal fluid barrier to DDAVP in patients with acquired communicating hydrocephalus. Eur J Clin Invest 1984;14: 435-9.